All Stories

  1. Comparative Real Life Egyptian Experience of the Combination of Sofosbuvir Plus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic Patients Infected with HCV Genotype 4

    Article • Current Drug Safety, May 2023, Bentham Science Publishers

    Essam Hassan

  2. Triggers for Acceptance of COVID-19 Vaccination: A Community- Based Study

    Article • Recent Advances in Anti-Infective Drug Discovery, March 2023, Bentham Science Publishers

    Mohamed Nour, Essam Hassan, Samy Zaky, sherief Abd-Elsalam, Heba Aly, Dr. Amin Abdel Baki, Ahmed Yousef

  3. adverse effects of direct antiviral drugs for HCV infection in Egypt

    Article • Current Drug Safety, September 2018, Bentham Science Publishers

    eman ibrahim ahmed, Wafaa Abdel-Wahed, Essam Hassan